June 20, 2019
The University of California San Diego ranked 4th among public research universities in the United States in this year’s annual ranking of high-quality scientific research papers by the journal Nature.
March 14, 2016
…indisputable. Emerging treatments using stem cells and immune cells are poised to most benefit from cell tracking, which would visualize their behavior in the body after delivery. Clinicians require such data to speed these cell treatments to patients. Researchers at University of California, San Diego School of Medicine describe a…
September 4, 2012
…the UC San Diego Stem Cell Research program and funded by the California Institute for Regenerative Medicine (CIRM) looks at an important RNA binding protein called LIN28, which is implicated in pluripotency and reprogramming as well as in cancer and other diseases. According to the researchers, their study – published…
July 11, 2012
Three recent graduates of the University of California, San Diego—Vickie Do, ’09, Stephanie Kinkel, ’05 and Michelle Lee, ’10—have been named Knowles Science Teaching Fellows and will each receive a $175,000 award from the Knowles Science Teaching Foundation.
November 9, 2015
…for their expertise in preclinical modeling, clinical trials and stem cell biology to join a “dream team” of international pancreatic cancer researchers.
April 18, 2023
An Olympic Gold Medalist, a MacArthur Fellow and the first woman to serve as director of the NASA Jet Propulsion Laboratory will lead an inspiring discussion that challenges the status quo at the fifth annual Women in Leadership.
September 26, 2024
UC San Diego researchers discover two distinct molecular subtypes of Crohn’s disease using patient-derived organoids, opening the door to personalized treatment for the chronic inflammatory bowel disease.
January 20, 2021
UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma.
November 30, 2017
Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug resistant. In a paper published online in the journal Cancer Cell on November 30, University of California San Diego School of Medicine researchers identified a strategy that pinpoints a genetically…
June 29, 2018
…natural killer (NK) cells derived from human induced pluripotent stem cells (iPSCs) also displayed heightened activity against a mouse model of ovarian cancer.
